Is it safe to use erectile dysfunction medication containing apomorphine (e.g., sublingual apomorphine tablets) in a patient who is using kratom?

Apomorphine for Erectile Dysfunction in Kratom Users

Sublingual apomorphine can be safely used in patients taking kratom, as there are no documented drug interactions between these substances, and apomorphine offers a unique safety advantage over PDE5 inhibitors in patients with cardiovascular contraindications.

Key Clinical Considerations

Safety Profile with Kratom

The available evidence shows no pharmacological basis for concern when combining sublingual apomorphine with kratom use:

• No documented interactions exist between apomorphine (a dopamine D1/D2 receptor agonist) and kratom (a μ-opioid receptor agonist) 1
• Apomorphine's central dopaminergic mechanism of action operates through different pathways than kratom's opioid receptor activity
• The kratom study specifically assessed sexual health impacts but identified no contraindications with ED medications 1

Apomorphine's Clinical Role

Apomorphine sublingual is most appropriate as a second-line option when PDE5 inhibitors are contraindicated or have failed 2, 3:

• Efficacy: Achieves 48-53% success rate for intercourse attempts versus 35% with placebo 4
• Optimal dosing: 2-3 mg sublingual provides the best therapeutic index with fewer adverse events 4
• Dose optimization strategy: Start at 2 mg and titrate based on response over 4 weeks 4

Critical Safety Advantage

Apomorphine is the only licensed oral ED medication NOT absolutely contraindicated with nitrate use 2:

• While PDE5 inhibitors cause dangerous hypotension with nitrates, apomorphine shows only modest blood pressure effects even with long-acting nitrates (systolic decrease of 5-9 mmHg when standing) 5
• This makes it uniquely valuable for patients with cardiovascular disease requiring nitrate therapy

Important Caveats

Common side effects are dose-dependent 4:

• Nausea (most common, diminishes substantially after 4 weeks)
• Dizziness and headache
• Discontinuation rates higher at doses above 3 mg

Limited efficacy in specific populations 2:

• Post-radical prostatectomy patients show minimal benefit
• Diabetic patients demonstrate reduced response
• Patients with multiple vascular risk factors respond poorly 6

Practical Recommendation for Kratom Users

For a patient using kratom who needs ED treatment:

1. First-line: PDE5 inhibitors remain superior in efficacy unless contraindicated 3, 7
2. Consider apomorphine if: Patient is on nitrates, has failed PDE5 inhibitors, or prefers non-PDE5 inhibitor therapy
3. Dosing protocol: Begin with 2 mg sublingual, assess response after 4 weeks, may increase to 3 mg if needed 4
4. Monitor for: Orthostatic hypotension, especially if patient takes alpha-blockers or calcium channel blockers 5

The combination of kratom and apomorphine carries no specific safety concerns beyond the individual side effect profiles of each substance.